Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Xenon Pharmaceuticals Inc., 3 years.
Xenon Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | Xenon Pharmaceuticals Inc. | Option exercise | +2,645 | — | — |
| Jun 1, 2026 | Xenon Pharmaceuticals Inc. | Shares withheld for tax | −1,416 | $53.41 | $75,629 |
| May 12, 2026 | Xenon Pharmaceuticals Inc. | Option exercise | +3,500 | $7.38 | $25,830 |
| Jun 5, 2025 | Xenon Pharmaceuticals Inc. | Open-market sale | −3 | $30.48 | $91 |
| May 14, 2025 | Xenon Pharmaceuticals Inc. | Option exercise | +5,144 | $12.57 | $64,660 |
| Mar 7, 2024 | Xenon Pharmaceuticals Inc. | Open-market sale | −1,000 | $46.45 | $46,450 |
| Mar 7, 2024 | Xenon Pharmaceuticals Inc. | Open-market sale | −5,000 | $46.25 | $231,250 |
| Mar 7, 2024 | Xenon Pharmaceuticals Inc. | Open-market sale | −5,000 | $46.30 | $231,500 |
| Mar 7, 2024 | Xenon Pharmaceuticals Inc. | Open-market sale | −2,000 | $46.20 | $92,400 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.